Tsur David received 37,500 KAMADA LTD derivative securities across two transactions dated 2026-08-27, with each recorded at $0 per share. The disclosure gives investors a defined post-transaction position of 30,000 derivative securities and identifies the entries as awards or grants rather than market purchases.

Key Highlights

  • Tsur David’s two transactions covered a total of 37,500 derivative securities.
  • The transactions were recorded on 27 August 2026 at $0 per share.
  • His reported position after the transactions was 30,000 derivative securities.

KAMADA LTD (NASDAQ: KMDA) is a biotechnology company. Director Tsur David received 37,500 derivative securities through two transactions dated 27 August 2026, with the securities recorded at $0 per share. His reported position after those transactions was 30,000 derivative securities.

KAMADA Director Award Details

The combined amount awarded to David was 37,500. Each transaction carried a price of $0 per share, and both were dated 27 August 2026. Tsur David is identified as a director of KAMADA LTD.